110 related articles for article (PubMed ID: 3362744)
1. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Peptides; 1988; 9(1):203-6. PubMed ID: 3362744
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
[TBL] [Abstract][Full Text] [Related]
4. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
5. A new kinin moiety in human plasma kininogens.
Mindroiu T; Carretero OA; Proud D; Walz D; Scicli AG
Biochem Biophys Res Commun; 1988 Apr; 152(2):519-26. PubMed ID: 3365237
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
7. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
8. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
Hilgenfeldt U; Stannek C; Lukasova M; Schnölzer M; Lewicka S
Br J Pharmacol; 2005 Dec; 146(7):958-63. PubMed ID: 16231010
[TBL] [Abstract][Full Text] [Related]
9. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides.
Okunishi H; Spragg J; Burton J; Toda N
Adv Exp Med Biol; 1989; 247B():23-8. PubMed ID: 2481944
[TBL] [Abstract][Full Text] [Related]
10. The myostimulating effect of tissue kallikrein on rat uterus.
Damas J; Bourdon V; Pinto JC
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):535-41. PubMed ID: 7643918
[TBL] [Abstract][Full Text] [Related]
11. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
[TBL] [Abstract][Full Text] [Related]
12. Kinins contribute to the contractile effects of rat glandular kallikrein on the isolated rat uterus.
Orce GG; Carretero OA; Scicli G; Scicli AG
J Pharmacol Exp Ther; 1989 May; 249(2):470-5. PubMed ID: 2724135
[TBL] [Abstract][Full Text] [Related]
13. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
15. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
16. Isolation of [hydroxyproline3]Lysyl-bradykinin formed by kallikrein from human plasma protein.
Sasaguri M; Ikeda M; Ideishi M; Arakawa K
Adv Exp Med Biol; 1989; 247A():539-44. PubMed ID: 2603820
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
[TBL] [Abstract][Full Text] [Related]
18. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.
Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR
Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266
[TBL] [Abstract][Full Text] [Related]
19. In vivo assay of specific kallikrein inhibitors.
Okunishi H; Spragg J; Burton J
Agents Actions Suppl; 1987; 22():381-90. PubMed ID: 3481213
[TBL] [Abstract][Full Text] [Related]
20. Identification of [hydroxyproline3]-lysyl-bradykinin released from human plasma protein by kallikrein.
Sasaguri M; Ikeda M; Ideishi M; Arakawa K
Biochem Biophys Res Commun; 1988 Jan; 150(1):511-6. PubMed ID: 3337729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
